Moreover, when introducing another ERα-positive cell line, T47D, to the PDS system it was clear that the drug effect was to a large extent the driver of the cellular response, more than the differences between cancer cell lines, which confirms the robustness of the system14,15. Here, ESR1 is linked to cancer.